| 1 |
2020 |
A 3D-printed biomaterials-based platform to advance established therapy avenues against primary bone cancers. |
3DPDDS, DOX, mPCL |
| 2 |
2020 |
A Bibliometric Analysis and Visualization of Current Research Trends in Chinese Medicine for Osteosarcoma. |
CM, WoS |
| 3 |
2020 |
A comprehensive analysis for associations between multiple microRNAs and prognosis of osteosarcoma patients. |
HR, miRNAs |
| 4 |
2020 |
A comprehensive evaluation of single nucleotide polymorphisms associated with osteosarcoma risk: A protocol for systematic review and network meta-analysis. |
SNPs |
| 5 |
2020 |
A four-methylated LncRNA signature predicts survival of osteosarcoma patients based on machine learning. |
ROC |
| 6 |
2020 |
A risk signature-based on metastasis-associated genes to predict survival of patients with osteosarcoma. |
--- |
| 7 |
2020 |
Aberrant epigenetic silencing of neuronatin is a frequent event in human osteosarcoma. |
ER, NNAT |
| 8 |
2020 |
Acquisition of cancer stem cell properties in osteosarcoma cells by defined factors. |
ANOVA, CSCs, KLF4, SOX2 |
| 9 |
2020 |
Acquisition of stem associated-features on metastatic osteosarcoma cells and their functional effects on mesenchymal stem cells. |
MSCs |
| 10 |
2020 |
Activation of TLR4 signaling inhibits progression of osteosarcoma by stimulating CD8-positive cytotoxic lymphocytes. |
LPS, TLR4 |
| 11 |
2020 |
ACTN4 Promotes the Proliferation, Migration, Metastasis of Osteosarcoma and Enhances its Invasive Ability through the NF-kappaB Pathway. |
ACTN4, HE |
| 12 |
2020 |
ADAMTS7 degrades Comp to fuel BMP2-dependent osteogenic differentiation and ameliorate oncogenic potential in osteosarcomas. |
BMP, COMP |
| 13 |
2020 |
Aerosolized Chemotherapy for Osteosarcoma. |
--- |
| 14 |
2020 |
ALKBH5-mediated m6A demethylation of lncRNA PVT1 plays an oncogenic role in osteosarcoma. |
lncRNA, m6A, MeRIP, PVT1, RIP |
| 15 |
2020 |
Analysis of Transcriptomic Similarity between Osteosarcoma Cell Lines and Primary Tumors. |
--- |
| 16 |
2020 |
Anticancer effects and the mechanism underlying 2-methoxyestradiol in human osteosarcoma in vitro and in vivo. |
2-ME, VEGF |
| 17 |
2020 |
Ascorbate sensitizes human osteosarcoma cells to the cytostatic effects of cisplatin. |
--- |
| 18 |
2020 |
Aurora-B Promotes Osteosarcoma Cell Growth and Metastasis Through Activation of the NPM1/ERK/NF-kappabeta/MMPs Axis. |
IF |
| 19 |
2020 |
Autophagy in Osteosarcoma. |
--- |
| 20 |
2020 |
Autophagy regulation by microRNAs: Novel insights into osteosarcoma therapy. |
miRNAs |
| 21 |
2020 |
beta-Elemonic acid inhibits the growth of human Osteosarcoma through endoplasmic reticulum (ER) stress-mediated PERK/eIF2alpha/ATF4/CHOP activation and Wnt/beta-catenin signal suppression. |
beta-EA, CHOP, ER, UPR |
| 22 |
2020 |
Bioengineered miR-328-3p modulates GLUT1-mediated glucose uptake and metabolism to exert synergistic antiproliferative effects with chemotherapeutics. |
BERA |
| 23 |
2020 |
Biology and pathogenesis of human osteosarcoma. |
--- |
| 24 |
2020 |
Bone Diseases: Current Approach and Future Perspectives in Drug Delivery Systems for Bone Targeted Therapeutics. |
NPs |
| 25 |
2020 |
C-terminal of E1A binding protein 2 promotes the malignancy of osteosarcoma cells via JAK1/Stat3 signaling. |
--- |
| 26 |
2020 |
CacyBP/SIP promotes tumor progression by regulating apoptosis and arresting the cell cycle in osteosarcoma. |
--- |
| 27 |
2020 |
Cadmium in bone cement induces necrosis and decreases the viability of residual osteosarcoma cells: A xenograft study. |
--- |
| 28 |
2020 |
Calycosin induces apoptosis in osteosarcoma cell line via ERbeta‑mediated PI3K/Akt signaling pathways. |
ER |
| 29 |
2020 |
Camptothecin induced DDX5 degradation increased the camptothecin resistance of osteosarcoma. |
CPT |
| 30 |
2020 |
CDKL3 promotes osteosarcoma progression by activating Akt/PKB. |
CDKL3 |
| 31 |
2020 |
CDKN2B-AS1 Exerts Oncogenic Role in Osteosarcoma by Promoting Cell Proliferation and Epithelial to Mesenchymal Transition. |
CDKN2B-AS1, EMT, lncRNAs |
| 32 |
2020 |
Characterization of LncRNA SNHG22 as a protector of NKIRAS2 through miR-4492 binding in osteosarcoma. |
ceRNA, EMT, HUVECs, LncRNA, NKIRAS2, SNHG22, SNHGs |
| 33 |
2020 |
Characterization of PD-1/PD-L1 Immune Checkpoint Expression in Osteosarcoma. |
ALP, SUV |
| 34 |
2020 |
Chimeric Antigen Receptor-modified T cells targeting EphA2 for the immunotherapy of paediatric bone tumours. |
CAR, EphA2, ES |
| 35 |
2020 |
Chlorogenic acid activates ERK1/2 and inhibits proliferation of osteosarcoma cells. |
CGA |
| 36 |
2020 |
Circ-XPO1 upregulates XPO1 expression by sponging multiple miRNAs to facilitate osteosarcoma cell progression. |
circRNAs |
| 37 |
2020 |
Circ-XPR1 promotes osteosarcoma proliferation through regulating the miR-214-5p/DDX5 axis. |
circRNAs |
| 38 |
2020 |
Circ0085539 Promotes Osteosarcoma Progression by Suppressing miR-526b-5p and PHLDA1 Axis. |
IHC, PHLDA1 |
| 39 |
2020 |
Circ100284 promotes invasion and migration of osteosarcoma cells by down-regulating PTEN and EMP1. |
CCK-8, ChIP, EMP1, EZH2, LSD1, PTEN, qRT-PCR |
| 40 |
2020 |
CircECE1 activates energy metabolism in osteosarcoma by stabilizing c-Myc. |
circRNAs, TXNIP |
| 41 |
2020 |
CircEIF4G2 Promotes Tumorigenesis and Progression of Osteosarcoma by Sponging miR-218. |
circRNAs |
| 42 |
2020 |
circKMT2D contributes to H2O2-attenuated osteosarcoma progression via the miR-210/autophagy pathway. |
circRNAs |
| 43 |
2020 |
circPVT1 Facilitates Invasion and Metastasis by Regulating miR-205-5p/c-FLIP Axis in Osteosarcoma. |
circRNA, EMT |
| 44 |
2020 |
CircRNA Circ_0001721 Promotes the Progression of Osteosarcoma Through miR-372-3p/MAPK7 Axis. |
circRNAs, EMT, MAPK7, MTT, qRT-PCR, RIP |
| 45 |
2020 |
CircSAMD4A regulates cell progression and epithelial‑mesenchymal transition by sponging miR‑342‑3p via the regulation of FZD7 expression in osteosarcoma. |
EMT, FZD7 |
| 46 |
2020 |
circSMARCA5 Promoted Osteosarcoma Cell Proliferation, Adhesion, Migration, and Invasion through a Competing Endogenous RNA Network. |
circRNAs |
| 47 |
2020 |
CircUBAP2 promotes SEMA6D expression to enhance the cisplatin resistance in osteosarcoma through sponging miR-506-3p by activating Wnt/beta-catenin signaling pathway. |
circRNAs, miR-506-3p, qRT-PCR, SEMA6D |
| 48 |
2020 |
Circular RNA 0060428 sponges miR-375 to promote osteosarcoma cell proliferation by upregulating the expression of RPBJ. |
circRNAs |
| 49 |
2020 |
Circular RNA circCCDC66 Contributes to Malignant Phenotype of Osteosarcoma by Sponging miR-338-3p to Upregulate the Expression of PTP1B. |
circRNAs |
| 50 |
2020 |
Circular RNA circFAT1(e2) Promotes Osteosarcoma Progression and Metastasis by Sponging miR-181b and Regulating HK2 Expression. |
ceRNA, circRNAs |
| 51 |
2020 |
Circular RNA circHIPK3 Promotes Cell Metastasis through miR-637/STAT3 Axis in Osteosarcoma. |
--- |
| 52 |
2020 |
Circular RNA CircITGA7 Promotes Tumorigenesis of Osteosarcoma via miR-370/PIM1 Axis. |
circRNA |
| 53 |
2020 |
Circular RNA circTUBGCP3 Is Up-Regulated and Promotes Cell Proliferation, Migration and Survivability via Sponge mir-30b in Osteosarcoma. |
--- |
| 54 |
2020 |
Circular RNA circUBAP2 regulates proliferation and invasion of osteosarcoma cells through miR-641/YAP1 axis. |
3'UTR, CCK-8, circRNAs, EMT, qRT-PCR, YAP1 |
| 55 |
2020 |
Circular RNA circ_0000337 contributes to osteosarcoma via the miR-4458/BACH1 pathway. |
--- |
| 56 |
2020 |
Circular RNA circ_0001105 Inhibits Progression and Metastasis of Osteosarcoma by Sponging miR-766 and Activating YTHDF2 Expression. |
circRNAs, ISH |
| 57 |
2020 |
Circular RNA hsa_circ_0000073 contributes to osteosarcoma cell proliferation, migration, invasion and methotrexate resistance by sponging miR-145-5p and miR-151-3p and upregulating NRAS. |
circRNAs |
| 58 |
2020 |
Circular RNA hsa_circ_0001649 suppresses the growth of osteosarcoma cells via sponging multiple miRNAs. |
circRNA |
| 59 |
2020 |
Circular RNA hsa_circ_0002052 promotes osteosarcoma via modulating miR-382/STX6 axis. |
circRNAs |
| 60 |
2020 |
Circular RNA hsa_circ_0003496 Contributes to Tumorigenesis and Chemoresistance in Osteosarcoma Through Targeting (microRNA) miR-370/Kruppel-Like Factor 12 Axis. |
CCK-8, circRNAs, DXR, KLF12, qRT-PCR, RIP |
| 61 |
2020 |
Circular RNA hsa_circ_0005909 modulates osteosarcoma progression via the miR-936/HMGB1 axis. |
CCK-8, EMT, HMGB1, qRT-PCR |
| 62 |
2020 |
Circular RNA PVT1 promotes metastasis via regulating of miR-526b/FOXC2 signals in OS cells. |
circPVT1, circRNAs, miR-526b, MREs |
| 63 |
2020 |
Circular RNA_CNST Promotes the Tumorigenesis of Osteosarcoma Cells by Sponging miR-421. |
circRNAs, FISH, PCR |
| 64 |
2020 |
Circ_0000285 regulates proliferation, migration, invasion and apoptosis of osteosarcoma by miR-409-3p/IGFBP3 axis. |
circRNAs, IGFBP-3, qRT-PCR, RIP |
| 65 |
2020 |
Circ_0000885 Enhances Osteosarcoma Progression by Increasing FGFR1 Expression via Sponging MiR-1294. |
circRNAs, FGFR1, qRT-PCR, WB |
| 66 |
2020 |
Circ_0001658 promotes the proliferation and metastasis of osteosarcoma cells via regulating miR-382-5p/YB-1 axis. |
circRNA, miRNA, YB-1 |
| 67 |
2020 |
circ_ARF3 regulates the pathogenesis of osteosarcoma by sponging miR-1299 to maintain CDK6 expression. |
--- |
| 68 |
2020 |
Circ_SIPA1L1 Promotes Osteosarcoma Progression Via miR-379-5p/MAP3K9 Axis. |
circRNAs, circ_SIPA1L1, miR-379-5p, qRT-PCR |
| 69 |
2020 |
Clinical Outcome of Free Vascularized Fibula Graft in the Surgical Treatment of Extremity Osteosarcoma. |
FVFG, MSTS |
| 70 |
2020 |
Clinical Significance of Cancer Stem Cell Markers CD133 and CXCR4 in Osteosarcomas. |
CSCs, CXCR4 |
| 71 |
2020 |
Co-expression network analysis identifies a gene signature as a predictive biomarker for energy metabolism in osteosarcoma. |
GO, KEGG, LASSO, WGCNA |
| 72 |
2020 |
Cold atmospheric plasma inhibits the growth of osteosarcoma cells by inducing apoptosis, independent of the device used. |
CAP |
| 73 |
2020 |
Cold Plasma-Treated Ringer's Saline: A Weapon to Target Osteosarcoma. |
PAR |
| 74 |
2020 |
Combinatorial Nanomedicine Made of Squalenoyl-Gemcitabine and Edelfosine for the Treatment of Osteosarcoma. |
EF, NAs, SQgem |
| 75 |
2020 |
Comparison of serum cytokine concentrations between healthy dogs and canine osteosarcoma patients at the time of diagnosis. |
IL-12p40, IL-8 |
| 76 |
2020 |
Comprehensive characterization of circular RNAs in osteosarcoma cell lines. |
ceRNA, circRNA, EMT |
| 77 |
2020 |
Comprehensive Characterization of Prognostic Long Noncoding RNAs in Osteosarcoma. |
CNA, GO, KEGG, lncRNAs |
| 78 |
2020 |
Conditioned medium of the osteosarcoma cell line U2OS induces hBMSCs to exhibit characteristics of carcinoma-associated fibroblasts via activation of IL-6/STAT3 signalling. |
BMSCs, CAFs, hBMSCs, U2OS |
| 79 |
2020 |
Confocal Raman microspectroscopic analysis on the time-dependent impact of DAPT, a gamma-secretase inhibitor, to osteosarcoma cells. |
CRM, KCA, LDA, PCA, UT |
| 80 |
2020 |
Construction of a circRNA-miRNA-mRNA network based on competitive endogenous RNA reveals the function of circRNAs in osteosarcoma. |
circRNAs, GEO, GO, KEGG |
| 81 |
2020 |
Construction of an integrated human osteosarcoma database, HOsDb, based on literature mining, microarray analysis, and database retrieval. |
miRNAs, SNPs, TFs |
| 82 |
2020 |
Correlation between the changes of serum COX 2, APE1, VEGF, TGF-beta and TSGF levels and prognosis in patients with osteosarcoma before and after treatment. |
bFGF, COX-2, TGF-beta, TSGF, VEGF |
| 83 |
2020 |
Cyanidin 3-O-Glucoside Induces the Apoptosis in the Osteosarcoma Cells through Upregulation of the PPARgamma and P21: An In Vitro Study. |
C3G, PCR |
| 84 |
2020 |
Cytological diagnosis of osteosarcoma with emphasis on diagnostic pitfalls. |
--- |
| 85 |
2020 |
Dedifferentiated low-grade central osteosarcoma with extensive cystic change initially treated as a simple bone cyst. |
LG-COS |
| 86 |
2020 |
Delineation of hypoxia-induced proteome shifts in osteosarcoma cells with different metastatic propensities. |
--- |
| 87 |
2020 |
Development of a novel immune-related genes prognostic signature for osteosarcoma. |
DEIRGs, GTEx, IRGs |
| 88 |
2020 |
Development of Natural-Based Bone Cement for a Controlled Doxorubicin-Drug Release. |
CPCs, DOXO, MSCs, NPs |
| 89 |
2020 |
DHRS12 inhibits the proliferation and metastasis of osteosarcoma via Wnt3a/beta-catenin pathway. |
--- |
| 90 |
2020 |
Differential expression of AURKA/PLK4 in quiescence and senescence of osteosarcoma U2OS cells. |
AURKA, DEGs |
| 91 |
2020 |
Dioscin inhibits the growth of human osteosarcoma by inducing G2/M-phase arrest, apoptosis, and GSDME-dependent cell death in vitro and in vivo. |
GSDME, PCD |
| 92 |
2020 |
Discovery of Cell-Surface Vimentin (CSV) as a Sarcoma Target and Development of CSV-Targeted IL12 Immune Therapy. |
CSV, CTCs, IL-12 |
| 93 |
2020 |
Down-regulation of LINC00472 promotes osteosarcoma tumorigenesis by reducing FOXO1 expressions via miR-300. |
--- |
| 94 |
2020 |
Down-regulation of MIAT suppresses osteosarcoma progression by acting as a ceRNA for miR-141-3p to regulate SIX1-mediated PI3K/AKT pathway. |
MIAT, PI3K, SIX1 |
| 95 |
2020 |
Down-regulation of miR-10b represses cell vitality in osteosarcoma and is inversely associated with prognosis via interacting with FAM46C: Running title: MiR-10b/FAM46C axis modulates OS progression. |
CCK-8, GEO |
| 96 |
2020 |
Down-regulation of PDGFRbeta suppresses invasion and migration in osteosarcoma cells by influencing epithelial-mesenchymal transition. |
mTOR, PDGFR, PI3K |
| 97 |
2020 |
Down-Regulation of Ribosomal Protein RPS21 Inhibits Invasive Behavior of Osteosarcoma Cells Through the Inactivation of MAPK Pathway. |
CCK-8, GEO, MAPK, qRT-PCR, RPS21 |
| 98 |
2020 |
Downregulated Long Non-Coding RNA MSC-AS1 Inhibits Osteosarcoma Progression and Increases Sensitivity to Cisplatin by Binding to MicroRNA-142. |
CDK6, lncRNA, miR, RT-qPCR |
| 99 |
2020 |
Downregulation of CDC20 suppressed cell proliferation, induced apoptosis, triggered cell cycle arrest in osteosarcoma cells, and enhanced chemosensitivity to cisplatin. |
CDC20 |
| 100 |
2020 |
Downregulation of lncRNA SNHG12 reversed IGF1R-induced osteosarcoma metastasis and proliferation by targeting miR-195-5p. |
IGF1R, lncSNHG12 |
A Search Service for Abbreviation / Long Form
